K251737

Substantially Equivalent

NextAR(TM) Shoulder Platform

Applicant: Medacta International S.A.
Product code: SBF
Advisory panel: Neurology
Date received: 2025-06-06
Decision date: 2025-09-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Castel San Pietro, CH

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.